Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label pharmacokinetic study in 16 healthy Thai subjects. To assess the safety
and tolerability and pharmacological interactions of the combination of
artemether-lumefantrine and amodiaquine.
Phase:
Phase 1
Details
Lead Sponsor:
University of Oxford
Collaborators:
Mahidol Oxford Tropical Medicine Research Unit Mahidol University
Treatments:
Amodiaquine Artemether Artemether, Lumefantrine Drug Combination Lumefantrine